287 studies found for:    "Pulmonary Emphysema"
Show Display Options
Rank Status Study
1 Recruiting Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)
Condition: Pulmonary Emphysema in Alpha-1 PI Deficiency
Interventions: Biological: Alpha1-proteinase inhibitor (human), modified process (Alpha-1 MP);   Other: 0.9% Sodium Chloride for Injection, USP
2 Recruiting Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema
Condition: Pulmonary Emphysema
Interventions: Biological: Mesenchymal stem cells;   Other: Reference therapy: 400 mL of 0.9% NaCl solution
3 Terminated Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation
Condition: Pulmonary Emphysema
Intervention: Biological: BLVR Hydrogel
4 Terminated Netherlands 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation
Condition: Pulmonary Emphysema
Intervention: Biological: BLVR Hydrogel
5 Recruiting Long Term Follow up Investigation of Endobronchial Valves in Emphysema
Condition: Pulmonary Emphysema
Intervention: Device: Zephyr Endobronchial Valve (EBV)
6 Terminated Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)
Condition: Pulmonary Emphysema
Interventions: Device: Treatment plus Optimal Medical Therapy;   Other: Optimal Medical Therapy
7 Completed Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study
Conditions: Pulmonary Emphysema;   Chronic Obstructive Pulmonary Disease
Intervention: Drug: Biologic Lung Volume Reduction (BLVR) - 10 mL Hydrogel
8 Completed US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study
Conditions: Pulmonary Emphysema;   Chronic Obstructive Pulmonary Disease
Intervention: Drug: Biologic Lung Volume Reduction (BLVR) - 20 mL Hydrogel
9 Completed US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study
Condition: Pulmonary Emphysema
Intervention: Drug: BLVR System
10 Completed US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study
Condition: Pulmonary Emphysema
Intervention: Biological: BLVR Treatment
11 Completed AeriSeal® System for Lung Volume Reduction in Patients With Advanced Emphysema
Conditions: Pulmonary Emphysema;   COPD;   Lung Diseases
Intervention: Device: AeriSeal System
12 Completed US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial Formulation
Condition: Pulmonary Emphysema
Intervention: Biological: BLVR
13 Recruiting The Effect and Mechanism of Bronchoscopic Lung Volume Reduction by Endobronchial Valve in Korean Emphysema Patients
Condition: Pulmonary Emphysema
Intervention: Device: Endobronchial valve
14 Unknown  AeriSeal System in Patients With Advanced Upper Lobe Predominant Emphysema and Collateral Ventilation
Conditions: Pulmonary Emphysema;   COPD;   Lung Diseases
Intervention: Device: AeriSeal System
15 Terminated A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema
Conditions: Pulmonary Emphysema;   Chronic Obstructive Pulmonary Disease(COPD);   Lung Diseases
Intervention: Device: AeriSeal System
16 Completed Extension Study of Zemaira® i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency.
Conditions: Emphysema;   Alpha 1-proteinase Inhibitor Deficiency
Intervention: Biological: Alpha1- proteinase inhibitor [human]
17 Completed AeriSeal System for Lung Volume Reduction
Conditions: Emphysema;   Chronic Obstructive Pulmonary Disease (COPD);   Pulmonary Emphysema;   Lung Diseases
Intervention: Device: AeriSeal System
18 Completed Safety Study of Bone-marrow Derived Mesenchymal Stromal Cells Associated With Endobronchial Valves in Emphysema
Condition: Pulmonary Emphysema
Intervention: Procedure: Bronchoscopy
19 Completed
Has Results
Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor Deficiency
Conditions: Alpha1-proteinase Inhibitor Deficiency;   Emphysema
Interventions: Biological: Alpha1-proteinase inhibitor;   Other: Placebo
20 Recruiting Low Cost Biological Lung Volume Reduction Therapy for Advanced Emphysema
Condition: Advanced Pulmonary Emphysema
Intervention: Procedure: Bronchoscopic Lung volume reduction

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years